Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


19.11.2018

1 Eur Heart J
1 Heart
3 Int J Cardiol
2 J Card Fail
2 J Cardiol
2 Lancet
1 N Engl J Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Eur Heart J

  1. NISHIMURA M, Maisel AS
    Biomarkers: a window into the pathophysiology of atrial fibrillation in heart failure with reduced vs. preserved ejection fraction.
    Eur Heart J. 2018;39:3876-3878.
    PubMed     Text format    


    Heart

  2. WILSON AJ, Gill EK, Abudalo RA, Edgar KS, et al
    Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.
    Heart. 2018;104:293-299.
    PubMed     Text format     Abstract available


    Int J Cardiol

  3. AIMO A, Januzzi JL Jr, Vergaro G, Ripoli A, et al
    High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.
    Int J Cardiol. 2018 Oct 26. pii: S0167-5273(18)32769.
    PubMed     Text format     Abstract available

  4. TSUJIMOTO T
    Low diastolic blood pressure for HFpEF.
    Int J Cardiol. 2018;270:190.
    PubMed     Text format    

  5. NIEDERER SA, Rinaldi CA
    Is CRT response rate all about patient selection?
    Int J Cardiol. 2018;270:183-184.
    PubMed     Text format    


    J Card Fail

  6. KIM DH, Shi SM
    Lower Extremity Function as a Marker of Frailty and Outcomes of Heart Failure with Preserved Ejection Fraction in Older Adults.
    J Card Fail. 2018 Nov 12. pii: S1071-9164(18)31182.
    PubMed     Text format    

  7. KHAN H, Anker SD, Januzzi JL, McGuire DK, et al
    Heart Failure Epidemiology in Patients with Diabetes Mellitus Without Coronary Heart Disease.
    J Card Fail. 2018 Nov 10. pii: S1071-9164(18)31120.
    PubMed     Text format     Abstract available


    J Cardiol

  8. JOHO S, Ushijima R, Nakagaito M, Kinugawa K, et al
    Relation between prognostic impact of hyperuricemia and sympathetic overactivation in patients with heart failure.
    J Cardiol. 2018 Nov 9. pii: S0914-5087(18)30286.
    PubMed     Text format     Abstract available

  9. ISOMI M, Sadahiro T, Ieda M
    Progress and Challenge of Cardiac Regeneration to Treat Heart Failure.
    J Cardiol. 2018 Nov 9. pii: S0914-5087(18)30287.
    PubMed     Text format     Abstract available


    Lancet

  10. WILCOX J, Yancy CW
    Stopping medication for heart failure with improved ejection fraction.
    Lancet. 2018 Nov 9. pii: S0140-6736(18)32825.
    PubMed     Text format    

  11. HALLIDAY BP, Wassall R, Lota AS, Khalique Z, et al
    Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.
    Lancet. 2018 Nov 9. pii: S0140-6736(18)32484.
    PubMed     Text format     Abstract available


    N Engl J Med

  12. VELAZQUEZ EJ, Morrow DA, DeVore AD, Duffy CI, et al
    Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
    N Engl J Med. 2018 Nov 11. doi: 10.1056/NEJMoa1812851.
    PubMed     Text format     Abstract available


    PLoS One

  13. TAKIMURA H, Hada T, Kawano M, Yabe T, et al
    A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.
    PLoS One. 2018;13:e0207481.
    PubMed     Text format     Abstract available

  14. AU-YEUNG WM, Reinhall PG, Bardy GH, Brunton SL, et al
    Development and validation of warning system of ventricular tachyarrhythmia in patients with heart failure with heart rate variability data.
    PLoS One. 2018;13:e0207215.
    PubMed     Text format     Abstract available

  15. CHEN TY, Kao CW, Cheng SM, Chang YC, et al
    Uncertainty and depressive symptoms as mediators of quality of life in patients with heart failure.
    PLoS One. 2018;13:e0205953.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: